Weight Loss Drug Ka Kamaal: GLP-1 Medicine Ne Heavy Drinking Ko 50% Kam Kiya!

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorKavya Nair|Published at:
Weight Loss Drug Ka Kamaal: GLP-1 Medicine Ne Heavy Drinking Ko 50% Kam Kiya!
Overview

Bhaiyo aur behno, suno! Weight loss ke liye jo popular GLP-1 drugs hain na, jaise ki semaglutide, unka ek naya kamaal samne aaya hai. Ek chhote se trial mein pata chala hai ki ye drugs heavy drinking wale dinon ko **50%** tak kam kar sakte hain!

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Ye Wazan Kam Karne Wali Medicine Hai Ya Kuch Aur?

Semaglutide, jo aajkal obesity ke liye bahut charcha mein hai, alcohol kam peene mein bhi kaafi effective nikli hai. Ek recent trial mein 108 patients ko observe kiya gaya. Jinko ye weekly injection mil raha tha, unke heavy drinking ke din, placebo group ke compare mein lagbhag 50% kam ho gaye.

Lancet Study Ke Chhote Par Bade Findings

Jo study The Lancet mein publish hui hai, uske according, semaglutide wale patients ke 17 heavy drinking days per month se ghat kar sirf 5 din reh gaye. Alcohol consumption bhi 2,200 grams per month se kam hokar 650 grams ho gaya. Haan, ye trial abhi chhota tha aur long-term data nahi hai, par ye results alcohol use disorder ke liye ek naye treatment ka bada hope dikha rahe hain.

Addiction Treatment Mein Naya Future?

Duniya bhar mein laakhon log alcohol use disorder se pareshan hain aur treatment options bhi limited hain. Ye dekhna dilchasp hoga ki kya ye commonly used weight-loss medication addiction ke liye ek effective therapy ban sakti hai. Pharmaceutical companies ke liye bhi ye ek bada market opportunity ho sakti hai.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.